Trial intelligence / Profile preview

Every other day Vonoprazan vs lansoprazole for maintenance treatment of erosive GERD

jRCTs031180102Completed

Sponsor
National Hospital Organization
Start
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of vonoprazan in erosive esophagitis (EE) (2 arms), sponsored by National Hospital Organization. Primary endpoint: Proportion of asymptomatic patients (overall). Started Dec 2017; status: completed.

02

Drugs

vonoprazan
03

Conditions

erosive esophagitis (EE)

Beyond the preview

Go deeper on jRCTs031180102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031180102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call